The Role of E-cadherin N-glycans in Oral Cancer
E-钙粘蛋白 N-聚糖在口腔癌中的作用
基本信息
- 批准号:7420929
- 负责人:
- 金额:$ 28.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAdhesivesAffectArchitectureArchivesBindingCancer cell lineCell ProliferationCell-Cell AdhesionCellsCharacteristicsComplexCytoskeletonDNA Sequence RearrangementDevelopmentDiagnosisDown-RegulationE-CadherinEpidermal Growth Factor ReceptorEpithelial CellsEventExtracellular DomainGlycoproteinsGoalsGrowthHumanIntegral Membrane ProteinIntercellular JunctionsInvadedLinkLocalizedMalignant Epithelial CellMalignant NeoplasmsMediatingMorphogenesisMouth NeoplasmsNatureNeoplasm MetastasisNumbersOperative Surgical ProceduresOralPatientsPhenotypePlayPolysaccharidesProliferatingProtein OverexpressionResearchResectedRoleSCID MiceSalivarySalivary GlandsSignal PathwaySignal TransductionSiteStagingStructureTailTestingTherapeuticTissuesTransmembrane DomainTransplantationTumor Suppressor ProteinsTumor TissueVariantadhesion receptorbasecancer cellcell motilityglycosylationin vivoinsightmalignant mouth neoplasmmigrationmouth squamous cell carcinomamutantnovelp27 Cell Cycle Proteinp27 Enzyme Inhibitorrho GTP-Binding Proteinssalivary cellstable cell linetumor
项目摘要
DESCRIPTION (provided by applicant): Oral cancer constitutes 1 of the most pernicious cancers with only a 5-year predicted survival following diagnosis. Our research proposes to elucidate some of the underlying causes of oral cancer by focusing on the nature of cell-cell contacts in human oral cancer cells. The long-term goal of our studies is to determine the role of N-glycosylation in the formation of E-cadherin-mediated cell-cell contacts in oral cancer cells. E-cadherin, with its documented role as a tumor suppressor, is the principal cell-cell adhesion receptor in oral epithelial cells. Although changes in N-glycan structures have long been known to be corollaries of tumor formation and metastasis, no information is available about how these structures affect E-cadherin adhesive function. E-cadherin ectodomains, which function in the formation of homotypic cell-cell contacts, have several potential N-glycan addition sites, while the cytosolic tail binds catenins that provide the linkage to the actin cytoskeleton. We have shown that during cell proliferation and migration, E-cadherin is extensively N-glycosylated and present in unstable cell-cell contacts. In contrast, in cytodifferentiated cells, E-cadherin is scarcely N-glycosylated and found in stable junctional complexes associated with the actin cytoskeleton. Our initial studies in vivo and ex vivo show that inappropriate increase in E-cadherin N-glycosylation in differentiated salivary cells reverses E-cadherin-mediated cell-cell contacts from stable to weak. Importantly, many cancer cells have highly N-glycosylated E-cadherin that is present in weak cell-cell contacts. Our hypothesis is that the N-glycosylation status of E- cadherin regulates its tumor suppressive function. We propose to test this hypothesis in 4 specific aims: 1) to demonstrate that highly N-glycosylated E-cadherin is a characteristic of oral cancer cell lines; 2) to show that high levels of E-cadherin N-glycosylation drive the formation of unstable E-cadherin-mediated cell-cell contacts; 3) to determine the signaling events through which N-glycosylation status of E-cadherin affects oral cancer cell proliferation and survival; and 4) to show that N-glycosylation status of E-cadherin regulates its tumor suppressive activity in SCID mice in vivo. Our proposed studies will increase the understanding of the basis of E-cadherin tumor suppressive activity in oral cancer and will serve as a basis for the development of novel treatment strategies.
描述(由申请人提供):口腔癌构成1个最有害的癌症中的1种,诊断后仅5年预测生存。我们的研究建议通过关注人口腔癌细胞的细胞 - 细胞接触性质来阐明口腔癌的某些潜在原因。我们研究的长期目标是确定N-糖基化在口腔癌细胞中E-钙粘蛋白介导的细胞接触形成中的作用。 E-钙粘着蛋白具有记录为肿瘤抑制剂的作用,是口腔上皮细胞中的主要细胞粘附受体。尽管长期以来已知N-聚糖结构的变化是肿瘤形成和转移的推论,但没有有关这些结构如何影响E-钙粘着蛋白粘附功能的信息。 E-钙粘蛋白的外生域在同型细胞 - 细胞接触形成中起作用,具有几个潜在的N-聚糖添加位点,而胞质尾巴则结合了链氨典蛋白,可提供与肌动蛋白细胞骨架的链接。我们已经表明,在细胞增殖和迁移期间,E-钙粘着蛋白是广泛的N-糖基化并存在于不稳定的细胞接触中。相比之下,在细胞区分化的细胞中,E-钙粘着蛋白几乎是N-糖基化的,并且在与肌动蛋白细胞骨架相关的稳定连接络合物中发现。我们在体内和体内的最初研究表明,分化的唾液细胞中E-钙粘着蛋白N-糖基化的不当增加会逆转E-钙粘蛋白介导的细胞 - 细胞接触从稳定到弱。重要的是,许多癌细胞具有高度N-糖基化的E-钙粘着蛋白,存在于弱细胞接触中。我们的假设是,cadherin的N-糖基化状态调节其肿瘤抑制功能。我们建议在4个特定目的中检验这一假设:1)证明高度N-糖基化的E-钙粘蛋白是口服癌细胞系的特征; 2)表明高水平的E-钙粘蛋白N-糖基化驱动不稳定的E-钙粘蛋白介导的细胞 - 细胞接触的形成; 3)确定e-钙粘着蛋白的N-糖基化状态的信号传导事件会影响口腔癌细胞的增殖和存活; 4)表明,E-钙粘蛋白的N-糖基化状态调节其在体内SCID小鼠中的肿瘤抑制活性。我们提出的研究将增加对口腔癌中电子钙粘蛋白抑制活性基础的理解,并将作为发展新治疗策略的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIA A. KUKURUZINSKA其他文献
MARIA A. KUKURUZINSKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIA A. KUKURUZINSKA', 18)}}的其他基金
Enhancement and Cloud Deployment of CaDrA, a software tool for Candidate Driver Analysis of Multiomics Data
CaDrA 的增强和云部署,这是一种用于多组学数据候选驱动程序分析的软件工具
- 批准号:
10406590 - 财政年份:2021
- 资助金额:
$ 28.71万 - 项目类别:
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
定义头颈癌中的 β-连环蛋白/CBP-连环蛋白/CBP 轴
- 批准号:
10312814 - 财政年份:2020
- 资助金额:
$ 28.71万 - 项目类别:
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer
定义头颈癌中的 β-连环蛋白/CBP-连环蛋白/CBP 轴
- 批准号:
10521284 - 财政年份:2020
- 资助金额:
$ 28.71万 - 项目类别:
Repair, Regeneration and Fibrosis of the Salivary Gland
唾液腺的修复、再生和纤维化
- 批准号:
9098687 - 财政年份:2015
- 资助金额:
$ 28.71万 - 项目类别:
2013 Salivary Glands and Exocrine Biology Gordon Research Conference
2013年唾液腺和外分泌生物学戈登研究会议
- 批准号:
8524089 - 财政年份:2013
- 资助金额:
$ 28.71万 - 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
- 批准号:
8170891 - 财政年份:2010
- 资助金额:
$ 28.71万 - 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
- 批准号:
7955918 - 财政年份:2009
- 资助金额:
$ 28.71万 - 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
- 批准号:
7723006 - 财政年份:2008
- 资助金额:
$ 28.71万 - 项目类别:
ROLE OF N-GLYCOSYLATION IN E-CADHERIN MEDIATED CELL-CELL ADHESION
N-糖基化在 E-钙粘蛋白介导的细胞粘附中的作用
- 批准号:
7602000 - 财政年份:2007
- 资助金额:
$ 28.71万 - 项目类别:
The Role of E-cadherin N-glycans in Oral Cancer
E-钙粘蛋白 N-聚糖在口腔癌中的作用
- 批准号:
7873024 - 财政年份:2006
- 资助金额:
$ 28.71万 - 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Investigating the epidermal microenvironment in melanoblast migration and invasion: a novel approach to understanding invasive melanoma
研究黑色素细胞迁移和侵袭的表皮微环境:一种了解侵袭性黑色素瘤的新方法
- 批准号:
10537221 - 财政年份:2023
- 资助金额:
$ 28.71万 - 项目类别:
Decoding cortical Notch signaling and morphogenic instruction at cell-cell interfaces
解码细胞-细胞界面的皮质Notch信号传导和形态发生指令
- 批准号:
10714471 - 财政年份:2023
- 资助金额:
$ 28.71万 - 项目类别:
Mechanisms of regulation of lymphocyte migration by actin cytoskeletal effectors
肌动蛋白细胞骨架效应器调节淋巴细胞迁移的机制
- 批准号:
10709904 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
Polarity proteins and intestinal mucosal responses to inflammation and injury
极性蛋白和肠粘膜对炎症和损伤的反应
- 批准号:
10442201 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别:
Mechanisms of regulation of lymphocyte migration by actin cytoskeletal effectors
肌动蛋白细胞骨架效应器调节淋巴细胞迁移的机制
- 批准号:
10583309 - 财政年份:2022
- 资助金额:
$ 28.71万 - 项目类别: